Yale Cancer Center

https://www.yalecancercenter.org/

 

Lung
10:19

Yale Cancer Center

Using Biomarkers in Clinical Management of Patients With ES-SCLC

FEATURING Anne Chiang
  • 199 views
  • April 30, 2024
  • 2
13:21

Yale Cancer Center

Navigating the Terrain: Recent Treatment Strategies for EGFRm Advanced NSCLC

FEATURING Amin Nassar
  • 486 views
  • February 7, 2024
  • 1
09:28

Yale Cancer Center

The Future of Lung Cancer Care

FEATURING Marianne Davies
  • 573 views
  • December 21, 2023
  • 4
20:27

Yale Cancer Center

Progress in the Treatment of NSCLC

FEATURING Roy Herbst
  • 508 views
  • December 20, 2023
  • 3
19:16

Yale Cancer Center

Treatment Approach to ROS1 Rearranged NSCLC

FEATURING Michael Grant
  • 476 views
  • October 19, 2023
  • 2
14:45

Yale Cancer Center

KRAS G12C NSCLC Treatment Approach: Surveying OS Data, CNS Activity, Patient Selection, and How to Choose Between Available Agents

FEATURING Amin Nassar
  • 219 views
  • August 22, 2023
  • 1
01:42

ecancer

ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analysis of Adjuvant Osimertinib in Patients With Resected EGFRm Stage IB–IIIA NSCLC"

FEATURING Roy Herbst
  • 432 views
  • June 14, 2023
  • 3
12:40

Yale Cancer Center

Consolidation IO Following CRT in Stage III NSCLC

FEATURING Henry Park
  • 257 views
  • March 17, 2023
  • 2
35:51

Yale Cancer Center

Advancements in NSCLC: Multidisciplinary Case Panel Discussion

FEATURING Steven Benaderet, Michael Cohenuram, Sarah Goldberg, Vincent Mase Jr, Daniel Rudolph
  • 245 views
  • November 30, 2022
  • 1
13:44

Yale Cancer Center

Yale Cancer Center on Lung Cancer Screening

FEATURING Justin Blasberg
  • 200 views
  • August 23, 2022
  • 1
14:27

Yale Cancer Center

Yale Cancer Center on Lung Cancer Screening: Nurse Perspective

FEATURING Emily Kopas
  • 87 views
  • August 23, 2022
  • 1
10:02

i3 Health

2021 ES-SCLC Updates: Enhancing the Clinical Outcomes With Novel Therapeutic Strategies

FEATURING Anne Chiang
  • 66 views
  • July 22, 2021
09:41

Yale Cancer Center

2020 Advances in Lung Cancer: What Are the Biggest NSCLC IO Advantages? What Are the 1L Options in Advanced Disease? Is Chemo Necessary? What Are the Available SCLC Options?

FEATURING Anne Chiang
  • 48 views
  • December 9, 2020
07:08

Yale Cancer Center

Advances in Targeted Therapy for NSCLC: What Is the Importance of Biopsies in Identifying Acquired Resistance Mutations at Progression? How to Determine Who Will Benefit From Oral TKIs?

FEATURING Anne Chiang
  • 266 views
  • December 8, 2020
  • 1
14:03

Yale Cancer Center

ESMO 2019 Updated IMpower110 Trial Results: With Consistent OS/PFS Improvement, Atezolizumab Is a New 1st-Line Treatment Option for PD-L1-High Stage IV NSCLC

FEATURING Roy Herbst
  • 1,741 views
  • January 7, 2020
  • 9